Host immune responses to rhinovirus: Mechanisms in asthma

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 4, 2008, Pages 671-682

  Kelly, John T ^a   Busse, William W ^a  

^a Section of Allergy   (United States)

Author keywords

Asthma; exacerbation; immune response to virus; pathogenesis; rhinovirus

Indexed keywords

ANTIVIRUS AGENT; CORTICOSTEROID; IMIQUIMOD; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PLACEBO; PLECONARIL; RUPINTRIVIR;

ASTHMA; B LYMPHOCYTE; DISEASE CONTROL; DISEASE EXACERBATION; DRUG MECHANISM; EOSINOPHIL; EPITHELIUM CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATORY CELL; INNATE IMMUNITY; MACROPHAGE; MUCUS; NASAL PRURITUS; NEUTROPHIL; PRIORITY JOURNAL; REVIEW; RHINOVIRUS; SIDE EFFECT; T LYMPHOCYTE; VIRAL RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

ASTHMA; CELL MOVEMENT; EPITHELIAL CELLS; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION MEDIATORS; MACROPHAGES; PICORNAVIRIDAE INFECTIONS; RESPIRATORY TRACT INFECTIONS; RHINOVIRUS;

EID: 53049100006     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.08.013     Document Type: Review

References (116)

1. Lemanske Jr. R.F., Jackson D.J., Gangnon R.E., Evans M.D., Li Z., Shult P.A., et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 116 (2005) 571-577
2. Lee K.K., Hegele R.G., Manfreda J., Wooldrage K., Becker A.B., Ferguson A.C., et al. Relationship of early childhood viral exposures to respiratory symptoms, onset of possible asthma and atopy in high risk children: the Canadian Asthma Primary Prevention Study. Pediatr Pulmonol 42 (2007) 290-297
3. Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Campbell M.J., Josephs L.K., et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 154 (1996) 654-660
4. Nicholson K.G., Kent J., and Ireland D.C. Respiratory viruses and exacerbations of asthma in adults. BMJ 307 (1993) 982-986
5. Khetsuriani N., Kazerouni N.N., Erdman D.D., Lu X.Y., Redd S.C., Anderson L.J., et al. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol 119 (2007) 314-321
6. Wos M., Sanak M., Soja J., Olechnowicz H., Busse W.W., and Szczeklik A. The presence of rhinovirus in lower airways of patients with bronchial asthma. Am J Respir Crit Care Med 177 (2008) 1082-1089
7. Tapparel C., Junier T., Gerlach D., Cordey S., Van Belle S., Perrin L., et al. New complete genome sequences of human rhinoviruses shed light on their phylogeny and genomic features. BMC Genomics 8 (2007) 224
8. Ledford R.M., Patel N.R., Demenczuk T.M., Watanyar A., Herbertz T., Collett M.S., et al. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds. J Virol 78 (2004) 3663-3674
9. Greenberg S.B. Respiratory consequences of rhinovirus infection. Arch Intern Med 163 (2003) 278-284
10. Oberste M.S., Maher K., Kilpatrick D.R., and Pallansch M.A. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol 73 (1999) 1941-1948
11. Andries K., Dewindt B., Snoeks J., Wouters L., Moereels H., Lewi P.J., et al. Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J Virol 64 (1990) 1117-1123
12. Lau S.K., Yip C.C., Tsoi H.W., Lee R.A., So L.Y., Lau Y.L., et al. Clinical features and complete genome characterization of a distinct human rhinovirus (HRV) genetic cluster, probably representing a previously undetected HRV species, HRV-C, associated with acute respiratory illness in children. J Clin Microbiol 45 (2007) 3655-3664
13. Lee W.M., Kiesner C., Pappas T., Lee I., Grindle K., Jartti T., et al. A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants. PLoS ONE 2 (2007) 1-11
14. Heymann P.W., Carper H.T., Murphy D.D., Platts-Mills T.A., Patrie J., McLaughlin A.P., et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol 114 (2004) 239-247
15. Gern J.E., and Busse W.W. Relationship of viral infections to wheezing illnesses and asthma. Nat Rev Immunol 2 (2002) 132-138
16. McFadden Jr. E.R., Pichurko B.M., Bowman H.F., Ingenito E., Burns S., Dowling N., et al. Thermal mapping of the airways in humans. J Appl Physiol 58 (1985) 564-570
17. Papadopoulos N.G., Sanderson G., Hunter J., and Johnston S.L. Rhinoviruses replicate effectively at lower airway temperatures. J Med Virol 58 (1999) 100-104
18. Schroth M.K., Grimm E., Frindt P., Galagan D.M., Konno S.I., Love R., et al. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am J Respir Cell Mol Biol 20 (1999) 1220-1228
19. Gern J.E., Galagan D.M., Jarjour N.N., Dick E.C., and Busse W.W. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 155 (1997) 1159-1161
20. Malmstrom K., Pitkaranta A., Carpen O., Pelkonen A., Malmberg L.P., Turpeinen M., et al. Human rhinovirus in bronchial epithelium of infants with recurrent respiratory symptoms. J Allergy Clin Immunol 118 (2006) 591-596
21. Greve J.M., Davis G., Meyer A.M., Forte C.P., Yost S.C., Marlor C.W., et al. The major human rhinovirus receptor is ICAM-1. Cell 56 (1989) 839-847
22. Hofer F., Gruenberger M., Kowalski H., Machat H., Huettinger M., Kuechler E., et al. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc Natl Acad Sci U S A 91 (1994) 1839-1842
23. Smith C.W., Marlin S.D., Rothlein R., Toman C., and Anderson D.C. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 83 (1989) 2008-2017
24. Papi A., and Johnston S.L. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription. J Biol Chem 274 (1999) 9707-9720
25. Chen Y., Hamati E., Lee P.K., Lee W.M., Wachi S., Schnurr D., et al. Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways. Am J Respir Cell Mol Biol 34 (2006) 192-203
26. Papadopoulos N.G., Papi A., Meyer J., Stanciu L.A., Salvi S., Holgate S.T., et al. Rhinovirus infection up-regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells. Clin Exp Allergy 31 (2001) 1060-1066
27. Zhu Z., Tang W., Gwaltney Jr. J.M., Wu Y., and Elias J.A. Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kappaB. Am J Physiol 273 (1997) L814-L824
28. Terajima M., Yamaya M., Sekizawa K., Okinaga S., Suzuki T., Yamada N., et al. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1beta. Am J Physiol 273 (1997) L749-L759
29. Gern J.E., Dick E.C., Lee W.M., Murray S., Meyer K., Handzel Z.T., et al. Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol 156 (1996) 621-627
30. Laza-Stanca V., Stanciu L.A., Message S.D., Edwards M.R., Gern J.E., and Johnston S.L. Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production. J Virol 80 (2006) 8248-8258
31. Johnston S.L., Papi A., Monick M.M., and Hunninghake G.W. Rhinoviruses induce interleukin-8 mRNA and protein production in human monocytes. J Infect Dis 175 (1997) 323-329
32. Parry D.E., Busse W.W., Sukow K.A., Dick C.R., Swenson C., and Gern J.E. Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol 105 (2000) 692-698
33. Wolpe S.D., and Cerami A. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J 3 (1989) 2565-2573
34. Bloemen P.G., van den Tweel M.C., Henricks P.A., Engels F., Wagenaar S.S., Rutten A.A., et al. Expression and modulation of adhesion molecules on human bronchial epithelial cells. Am J Respir Cell Mol Biol 9 (1993) 586-593
35. Subauste M.C., Jacoby D.B., Richards S.M., and Proud D. Infection of a human respiratory epithelial cell line with rhinovirus: induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 96 (1995) 549-557
36. Fahy J.V., Kim K.W., Liu J., and Boushey H.A. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 95 (1995) 843-852
37. Gern J.E., Vrtis R., Grindle K.A., Swenson C., and Busse W.W. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 162 (2000) 2226-2231
38. Jarjour N.N., Gern J.E., Kelly E.A., Swenson C.A., Dick C.R., and Busse W.W. The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol 105 (2000) 1169-1177
39. Wark P.A., Johnston S.L., Moric I., Simpson J.L., Hensley M.J., and Gibson P.G. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 19 (2002) 68-75
40. Schuster A., Fahy J.V., Ueki I., and Nadel J.A. Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitors. Eur Respir J 8 (1995) 10-14
41. Fraenkel D.J., Bardin P.G., Sanderson G., Lampe F., Johnston S.L., and Holgate S.T. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 151 (1995) 879-886
42. Grunberg K., Smits H.H., Timmers M.C., de Klerk E.P., Dolhain R.J., Dick E.C., et al. Experimental rhinovirus 16 infection: effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med 156 (1997) 609-616
43. Pacifico L., Iacobini M., Viola F., Werner B., Mancuso G., and Chiesa C. Chemokine concentrations in nasal washings of infants with rhinovirus illnesses. Clin Infect Dis 31 (2000) 834-838
44. Rosenberg H.F., and Domachowske J.B. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol 70 (2001) 691-698
45. Phipps S., Lam C.E., Mahalingam S., Newhouse M., Ramirez R., Rosenberg H.F., et al. Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood 110 (2007) 1578-1586
46. Avila P.C., Abisheganaden J.A., Wong H., Liu J., Yagi S., Schnurr D., et al. Effects of allergic inflammation of the nasal mucosa on the severity of rhinovirus 16 cold. J Allergy Clin Immunol 105 (2000) 923-932
47. Jatakanon A., Lim S., and Barnes P.J. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 161 (2000) 64-72
48. Wang H.B., Ghiran I., Matthaei K., and Weller P.F. Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells. J Immunol 179 (2007) 7585-7592
49. Padigel U.M., Lee J.J., Nolan T.J., Schad G.A., and Abraham D. Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis. Infect Immun 74 (2006) 3232-3238
50. Lucey D.R., Nicholson-Weller A., and Weller P.F. Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci U S A 86 (1989) 1348-1351
51. Weller P.F., Rand T.H., Barrett T., Elovic A., Wong D.T., and Finberg R.W. Accessory cell function of human eosinophils: HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. J Immunol 150 (1993) 2554-2562
52. Guida L., O'Hehir R.E., and Hawrylowicz C.M. Synergy between dexamethasone and interleukin-5 for the induction of major histocompatibility complex class II expression by human peripheral blood eosinophils. Blood 84 (1994) 2733-2740
53. Hansel T.T., Braunstein J.B., Walker C., Blaser K., Bruijnzeel P.L., Virchow Jr. J.C., et al. Sputum eosinophils from asthmatics express ICAM-1 and HLA-DR. Clin Exp Immunol 86 (1991) 271-277
54. Sedgwick J.B., Calhoun W.J., Vrtis R.F., Bates M.E., McAllister P.K., and Busse W.W. Comparison of airway and blood eosinophil function after in vivo antigen challenge. J Immunol 149 (1992) 3710-3718
55. Ohkawara Y., Lim K.G., Xing Z., Glibetic M., Nakano K., Dolovich J., et al. CD40 expression by human peripheral blood eosinophils. J Clin Invest 97 (1996) 1761-1766
56. Handzel Z.T., Busse W.W., Sedgwick J.B., Vrtis R., Lee W.M., Kelly E.A., et al. Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol 160 (1998) 1279-1284
57. Mawhorter S.D., Kazura J.W., and Boom W.H. Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation. Immunology 81 (1994) 584-591
58. Levandowski R.A., Ou D.W., and Jackson G.G. Acute-phase decrease of T lymphocyte subsets in rhinovirus infection. J Infect Dis 153 (1986) 743-748
59. Wark P.A., Bucchieri F., Johnston S.L., Gibson P.G., Hamilton L., Mimica J., et al. IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations. J Allergy Clin Immunol 120 (2007) 586-593
60. Rabin R.L., Park M.K., Liao F., Swofford R., Stephany D., and Farber J.M. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. J Immunol 162 (1999) 3840-3850
61. Spurrell J.C., Wiehler S., Zaheer R.S., Sanders S.P., and Proud D. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 289 (2005) L85-L95
62. Odemuyiwa S.O., Ghahary A., Li Y., Puttagunta L., Lee J.E., Musat-Marcu S., et al. Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase. J Immunol 173 (2004) 5909-5913
63. Message S.D., and Johnston S.L. The immunology of virus infection in asthma. Eur Respir J 18 (2001) 1013-1025
64. Alper C.M., Doyle W.J., Skoner D.P., Buchman C.A., Seroky J.T., Gwaltney J.M., et al. Prechallenge antibodies: moderators of infection rate, signs, and symptoms in adults experimentally challenged with rhinovirus type 39. Laryngoscope 106 (1996) 1298-1305
65. Welliver R.C., Wong D.T., Sun M., Middleton E.J., Vaughan R.S., and Ogra P.L. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med 305 (1981) 841-846
66. Skoner D.P., Doyle W.J., Tanner E.P., Kiss J., and Fireman P. Effect of rhinovirus 39 (RV-39) infection on immune and inflammatory parameters in allergic and non-allergic subjects. Clin Exp Allergy 25 (1995) 561-567
67. Gern J.E., Martin M.S., Anklam K.A., Shen K., Roberg K.A., Carlson-Dakes K.T., et al. Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy. Pediatr Allergy Immunol 13 (2002) 386-393
68. van Benten I.J., KleinJan A., Neijens H.J., Osterhaus A.D., and Fokkens W.J. Prolonged nasal eosinophilia in allergic patients after common cold. Allergy 56 (2001) 949-956
69. Grissell T.V., Powell H., Shafren D.R., Boyle M.J., Hensley M.J., Jones P.D., et al. Interleukin-10 gene expression in acute virus-induced asthma. Am J Respir Crit Care Med 172 (2005) 433-439
70. Schall T.J., Bacon K., Camp R.D., Kaspari J.W., and Goeddel D.V. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med 177 (1993) 1821-1826
71. Gentile D.A., Fireman P., and Skoner D.P. Elevations of local leukotriene C4 levels during viral upper respiratory tract infections. Ann Allergy Asthma Immunol 91 (2003) 270-274
72. Jame A.J., Lackie P.M., Cazaly A.M., Sayers I., Penrose J.F., Holgate S.T., et al. Human bronchial epithelial cells express an active and inducible biosynthetic pathway for leukotrienes B4 and C4. Clin Exp Allergy 37 (2007) 880-892
73. Wark P.A., Johnston S.L., Bucchieri F., Powell R., Puddicombe S., Laza-Stanca V., et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 201 (2005) 937-947
74. Contoli M., Message S.D., Laza-Stanca V., Edwards M.R., Wark P.A., Bartlett N.W., et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 12 (2006) 1023-1026
75. Kling S., Donninger H., Williams Z., Vermeulen J., Weinberg E., Latiff K., et al. Persistence of rhinovirus RNA after asthma exacerbation in children. Clin Exp Allergy 35 (2005) 672-678
76. Corne J.M., Marshall C., Smith S., Schreiber J., Sanderson G., Holgate S.T., et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 359 (2002) 831-834
77. Papadopoulos N.G., Stanciu L.A., Papi A., Holgate S.T., and Johnston S.L. A defective type 1 response to rhinovirus in atopic asthma. Thorax 57 (2002) 328-332
78. Bousquet J., Khaltaev N., Cruz A.A., Denburg J., Fokkens W.J., Togias A., et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63 suppl 86 (2008) 8-160
79. Duff A.L., Pomeranz E.S., Gelber L.E., Price G.W., Farris H., Hayden F.G., et al. Risk factors for acute wheezing in infants and children: viruses, passive smoke and IgE antibodies to inhalant allergens. Pediatrics 92 (1993) 535-540
80. Heymann P.W., Rakes G.P., Hogan A.D., Ingram J.M., Hoober G.E., and Plansmills T.A.E. Assessment of eosinophils, viruses and IgE antibody in wheezing infants and children. Int Arch Allergy Immunol 107 (1995) 380-382
81. Zambrano J.C., Carper H.T., Rakes G.P., Patrie J., Murphy D.D., Platts-Mills T.A.E., et al. Experimental rhinovirus challenges in adults with mild asthma: response to infection in relation to IgE. J Allergy Clin Immunol 111 (2003) 1008-1016
82. Bianco A., Sethi S.K., Allen J.T., Knight R.A., and Spiteri M.A. Th2 cytokines exert a dominant influence on epithelial cell expression of the major group human rhinovirus receptor, ICAM-1. Eur Respir J 12 (1998) 619-626
83. Bianco A., Whiteman S.C., Sethi S.K., Allen J.T., Knight R.A., and Spiteri M.A. Expression of intercellular adhesion molecule-1 (ICAM-1) in nasal epithelial cells of atopic subjects: a mechanism for increased rhinovirus infection?. Clin Exp Immunol 121 (2000) 339-345
84. Murray C.S., Poletti G., Kebadze T., Morris J., Woodcock A., Johnston S.L., et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 61 (2006) 376-382
85. Bardin P.G., Fraenkel D.J., Sanderson G., Dorward M., Lau L.C.K., Johnston S.L., et al. Amplified rhinovirus colds in atopic subjects. Clin Exp Allergy 24 (1994) 457-464
86. Kluijver J.C., Evertse C.E., Sont J.K., Schrumpf J.A., Zeijl-van der Ham J.G., Dick C.R., et al. Are rhinovirus-induced airway responses in asthma aggravated by chronic allergen exposure?. Am J Respir Crit Care Med 168 (2003) 1174-1180
87. Pauwels R.A., Lofdahl C.G., Postma D.S., Tattersfield A.E., O'Byrne P., Barnes P.J., et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 337 (1997) 1405-1411
88. Venarske D.L., Busse W.W., Griffin M.R., Gebretsadik T., Shintani A.K., Minton P.A., et al. The relationship of rhinovirus-associated asthma hospitalizations with inhaled corticosteroids and smoking. J Infect Dis 193 (2006) 1536-1543
89. Grunberg K., Sharon R.F., Sont J.K., In 't Veen J.C., Van Schadewijk W.A., De Klerk E.P., et al. Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med 164 (2001) 1816-1822
90. Lehtinen P., Ruohola A., Vanto T., Vuorinen T., Ruuskanen O., and Jartti T. Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. J Allergy Clin Immunol 119 (2007) 570-575
91. Brunette M.G., Lands L., and Thibodeau L.P. Childhood asthma prevention of attacks with short-term corticosteroid treatment of upper respiratory tract infection. Pediatrics 81 (1988) 624-629
92. Edwards M.R., Haas J., Panettieri Jr. R.A., Johnson M., and Johnston S.L. Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements. J Biol Chem 282 (2007) 15366-15375
93. Pelaia G., Vatrella A., Cuda G., Maselli R., and Marsico S.A. Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases. Life Sci 72 (2003) 1549-1561
94. Pelaia G., Cuda G., Vatrella A., Grembiale R.D., De Sarro G., Maselli R., et al. Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells. Biochem Pharmacol 62 (2001) 1719-1724
95. Auphan N., DiDonato J.A., Rosette C., Helmberg A., and Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270 (1995) 286-290
96. Edwards M.R., Mukaida N., Johnson M., and Johnston S.L. IL-1beta induces IL-8 in bronchial cells via NF-kappaB and NF-IL6 transcription factors and can be suppressed by glucocorticoids. Pulm Pharmacol Ther 18 (2005) 337-345
97. Bisgaard H., Zielen S., Garcia-Garcia M.L., Johnston S.L., Gilles L., Menten J., et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 171 (2005) 315-322
98. Robertson C.F., Price D., Henry R., Mellis C., Glasgow N., Fitzgerald D., et al. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am J Respir Crit Care Med 175 (2007) 323-329
99. Hayden F.G., Albrecht J.K., Kaiser D.L., and Gwaltney Jr. J.M. Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. N Engl J Med 314 (1986) 71-75
100. Farr B.M., Gwaltney Jr. J.M., Adams K.F., and Hayden F.G. Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds. Antimicrob Agents Chemother 26 (1984) 31-34
101. Sperber S.J., and Hayden F.G. Comparative susceptibility of respiratory viruses to recombinant interferons-alpha 2b and -beta. J Interferon Res 9 (1989) 285-293
102. Sperber S.J., Levine P.A., Sorrentino J.V., Riker D.K., and Hayden F.G. Ineffectiveness of recombinant interferon-beta serine nasal drops for prophylaxis of natural colds. J Infect Dis 160 (1989) 700-705
103. Pevear D.C., Hayden F.G., Demenczuk T.M., Barone L.R., McKinlay M., and Collett M. Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinovirus. Antimicrob Agents Chemother 49 (2005) 4492-4499
104. Hayden F.G., Herrington D.T., Coats T.L., Kim K., Cooper E.C., Villano S.A., et al. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clin Infect Dis 36 (2003) 1523-1532
105. Fleischer R., and Laessig K. Safety and efficacy evaluation of pleconaril for treatment of the common cold. Clin Infect Dis 37 (2003) 1722
106. Stanley M.A. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol 27 (2002) 571-577
107. Clejan S., Mandrea E., Pandrea I.V., Dufour J., Japa S., and Veazey R.S. Immune responses induced by intranasal imiquimod and implications for therapeutics in rhinovirus infections. J Cell Mol Med 9 (2005) 457-461
108. Stokes J.R., Sorkness R.L., Kaplan M.R., Castleman W.L., Tomai M.A., Miller R.L., et al. Attenuation of virus-induced airway dysfunction in rats treated with imiquimod. Eur Respir J 11 (1998) 324-329
109. Hayden F.G., Gwaltney Jr. J.M., and Colonno R.J. Modification of experimental rhinovirus colds by receptor blockade. Antiviral Res 9 (1988) 233-247
110. Charles C.H., Luo G.X., Kohlstaedt L.A., Morantte I.G., Gorfain E., Cao L., et al. Prevention of human rhinovirus infection by multivalent fab molecules directed against ICAM-1. Antimicrob Agents Chemother 47 (2003) 1503-1508
111. Turner R.B., Wecker M.T., Pohl G., Witek T.J., McNally E., St George R., et al. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA 281 (1999) 1797-1804
112. Fendrick A.M. Viral respiratory infections due to rhinoviruses: current knowledge, new developments. Am J Ther 10 (2003) 193-202
113. Rotbart H.A. Antiviral therapy for enteroviruses and rhinoviruses. Antivir Chem Chemother 11 (2000) 261-271
114. Maugeri C., Alisi M.A., Apicella C., Cellai L., Dragone P., Fioravanzo E., et al. New anti-viral drugs for the treatment of the common cold. Bioorg Med Chem 16 (2008) 3091-3107
115. Zalman L.S., Brothers M.A., Dragovich P.S., Zhou R., Prins T.J., Worland S.T., et al. Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor. Antimicrob Agents Chemother 44 (2000) 1236-1241
116. Hayden F.G., Turner R.B., Gwaltney J.M., Chi-Burris K., Gersten M., Hsyu P., et al. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob Agents Chemother 47 (2003) 3907-3916